This is a preview of subscription content, log in via an institution to check access.
Notes
TGA = Therapeutic Goods Administration
Reference
Therapeutic Goods Administration. New precautions for hyoscine butylbromide ampoules. Medicines Safety Update 8: 2, No. 4, Aug-Sep 2017. Available from: URL: https://www.tga.gov.au/sites/default/files/medicines-safety-update-volume-8-number-4-august-september-2017.pdf
Rights and permissions
About this article
Cite this article
Updated precautions for hyoscine butylbromide in Australia. Reactions Weekly 1671, 5 (2017). https://doi.org/10.1007/s40278-017-36439-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-36439-9